Orbimed Advisors - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q2 2019$12,581,000
-54.2%
1,382,502
-30.2%
0.20%
-54.2%
Q1 2019$27,491,000
+21.2%
1,982,031
+37.9%
0.43%
+1.4%
Q4 2018$22,687,000
-42.5%
1,437,731
-29.4%
0.42%
-11.6%
Q3 2018$39,433,000
+314.6%
2,037,875
+56.4%
0.48%
+320.4%
Q2 2018$9,512,000
+137.4%
1,302,9550.0%0.11%
+126.0%
Q1 2018$4,007,000
-4.6%
1,302,9550.0%0.05%
-5.7%
Q4 2017$4,202,000
-62.3%
1,302,955
-43.2%
0.05%
-50.0%
Q3 2017$11,132,000
-7.1%
2,295,346
-0.4%
0.11%
-15.9%
Q2 2017$11,988,000
+4.0%
2,305,4460.0%0.13%
-3.8%
Q1 2017$11,527,000
+2.0%
2,305,4460.0%0.13%
-9.0%
Q4 2016$11,297,000
-26.5%
2,305,4460.0%0.14%
-17.7%
Q3 2016$15,377,000
+37.8%
2,305,4460.0%0.18%
+50.9%
Q2 2016$11,158,000
-0.8%
2,305,4460.0%0.12%
-1.7%
Q1 2016$11,251,000
-42.9%
2,305,446
+1.5%
0.12%
-34.1%
Q4 2015$19,717,000
-26.5%
2,271,500
+23.4%
0.18%
-33.9%
Q3 2015$26,829,000
-12.1%
1,841,400
+0.5%
0.27%
+21.0%
Q2 2015$30,529,000
-23.8%
1,831,4000.0%0.22%
-34.5%
Q1 2015$40,071,000
+1.1%
1,831,400
+0.1%
0.34%
-9.8%
Q4 2014$39,643,000
+142.7%
1,829,400
+92.6%
0.38%
+121.6%
Q3 2014$16,331,000950,0000.17%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders